FDA clears Covidien's latest Nellcor continuous respiratory monitor
Covidien wins FDA clearance for its Nellcor Bedside SpO2 patient monitoring system with continuous monitoring.
The device continuously monitors SpO2 and pulse rate for adult, pediatric and neonatal patients, providing access to comprehensive respiratory trends and subtle variations.
"Healthcare professionals on the general care floor, and in other lower-acuity areas of the hospital, need critical patient information at their fingertips so they can respond quickly to health threats," Covidien respiratory & monitoring solutions president Robert White said in prepared remarks . "By giving them ready access to a patient's respiratory history, the system allows them to focus on delivering efficient, high-quality care, not gathering and managing data."